Susquehanna Fundamental Investments, LLC Nu Cana PLC Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.74 - $3.27 $8,732 - $38,586	-11,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.02 - $2.9 $23,836 - $34,220	11,800 New	11,800 $28,000
Q3 2021 Nov 15, 2021	SELL	$1.95 - $2.85 $58,225 - $85,098	-29,859 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.7 - $5.04 $68,420 - $127,718	-25,341 Reduced 45.91%	29,859 $83,000
Q1 2021 May 17, 2021	BUY	$4.38 - $7.0 $241,776 - $386,400	55,200 New	55,200 $275,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $63.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.